
Wellgistics Health, Inc. (WGRX)
WGRX Stock Price Chart
Explore Wellgistics Health, Inc. interactive price chart. Choose custom timeframes to analyze WGRX price movements and trends.
WGRX Company Profile
Discover essential business fundamentals and corporate details for Wellgistics Health, Inc. (WGRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
25 Feb 2025
Employees
31.00
CEO
Prashant Patel
Description
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies. It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.
WGRX Financial Timeline
Browse a chronological timeline of Wellgistics Health, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 26 May 2026
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 19 May 2026
EPS came in at -$3.50 , while revenue for the quarter reached $1.56m .
Earnings released on 20 Mar 2026
EPS came in at -$6.50 , while revenue for the quarter reached $1.67m .
Earnings released on 19 Nov 2025
EPS came in at -$0.44 , while revenue for the quarter reached $3.01m .
Earnings released on 19 Aug 2025
EPS came in at -$0.11 , while revenue for the quarter reached $7.79m .
Earnings released on 12 May 2025
EPS came in at -$0.62 , while revenue for the quarter reached $10.86m .
Earnings released on 26 Mar 2025
EPS came in at -$0.08 , while revenue for the quarter reached -$16.05m .
WGRX Stock Performance
Access detailed WGRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.